Expanded newborn screening for biochemical disorders: The effect of a false-positive result

View online source

Authors:

Elizabeth A. Gurian

Daniel D. Kinnamon

Judith J. Henry

Susan E. Waisbren

Year:

2006

Pediatrics

Return to Search Results

Related Publications

Journal Article

Screening policy for cystic fibrosis. The role of evidence
Journal Article

Genomics is here: What can we do with it, and what ethical issues has it brought along for the ride?
Journal Article

The ethical hazards and programmatic challenges of genomic newborn screening
Journal Article

Addressing the burdens that newborn screening imposes on underserved communities
Journal Article

When less is more: Lessons for expanded carrier screening from newborn sequencing research
Journal Article

The BabySeq project: Implementing genomic sequencing in newborns
Journal Article

Is newborn screening for cystic fibrosis a basic human right?
Journal Article

Select ethical aspects of next-generation sequencing tests for newborn screening and diagnostic evaluation of critically ill newborns
Journal Article

Noninvasive prenatal genome sequencing:
Ethical and policy post-birth implications
Journal Article

Parents' decisions to screen newborns for FMR1 gene expansions in a pilot research project
Journal Article

Parental interest in genomic sequencing of newborns: Enrollment experience from the BabySeq Project
Journal Article

CFTR genotype analysis of Asians in international registries highlights disparities in the diagnosis and treatment of Asian patients with cystic fibrosis
Journal Article

Parents are interested in newborn genomic testing during the early postpartum period
Journal Article

Lessons that newborn screening in the USA can teach us about biobanking and large-scale genetic studies

Expanded newborn screening for biochemical disorders: The effect of a false-positive result

Authors:

Year:

Share

Related Publications

Newsletter